Abstract
Neural stem/progenitor cells (NSPCs) rely on internal and external cues determining their lineage decisions during brain development. The progenitor cells of the embryonic mammalian forebrain reside in the ventricular and subventricular zones of the lateral ventricles, where they proliferate, generate neurons and glial cells, and respond to external cues like growth factors. The extracellular matrix (ECM) surrounds NSPCs and influences the cell fate by providing mechanical scaffold, trophic support, and instructive signals. The ECM molecule tenascin-C (Tnc) is expressed in the proliferative zones of the develo** forebrain and involved in the proliferation and maturation of NSPCs. Here, we analyzed the regulation of the Tnc gene expression by NSPCs cultivated under the influence of different growth factors. We observed that the epidermal growth factor (EGF) and the fibroblast growth factor (FGF)-2 strongly increased the expression of Tnc, whereas the transforming growth factor (TGF)β 1 had no effect on Tnc gene expression, in contrast to previous findings in cell cultures of neural and non-neural origin. The stimulation of the Tnc gene expression induced by EGF or FGF-2 was reversible and seen in constantly treated as well as short term stimulated NSPC cultures. The activation depended on the presence of the respective receptors, which was slightly different in cortical and striatal NSPC cultures. Our results confirm the influence of extracellular stimuli regulating the expression of factors that form a niche for NSPCs during embryonic forebrain development.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
In the develo** mammalian forebrain, neural stem/progenitor cells (NSPCs) generate the cell types of the brain in a highly ordered process, which includes the proliferation and differentiation of these cells as reviewed in several publications (e.g., Dimou and Götz 2014; Heide et al. 2017; Taverna et al. 2014). The behavior of the NSPCs and their fate decision in either direction is influenced by intrinsic and extrinsic factors (Faissner et al. 2017; Heide et al. 2017; Martynoga et al. 2012; Pacary et al. 2012; Reinhard et al. 2016; Theocharidis et al. 2014). Two subpopulations of progenitor cells can be distinguished in the proliferative zones of the mammalian forebrain that are characterized by their ability to respond to the epidermal growth factor (EGF) or fibroblast growth factor 2 (FGF-2) (Ciccolini and Svendsen 1998; Martens et al. 2000; Temple 2001; Tropepe et al. 1999). These populations exhibit self-renewal and differentiation capacity, which defines them as stem cells. The stem cell characteristics of these cells can be analyzed in vitro, where they generate free-floating cell aggregates called neurospheres when cultured in defined medium conditions and generate neurons and glia cells under differentiating conditions (Ciccolini and Svendsen 1998; Martens et al. 2000; Reynolds and Weiss 1992). The distinct populations come up in a temporally and spatially ordered fashion during development. At the beginning of neurogenesis, FGF-2-responsive cells can be found in the neurogenic regions of the forebrain, whereas the EGF-responsive populations appear later, when gliogenesis begins (Ciccolini and Svendsen 1998; Martens et al. 2000; Temple 2001; Zhu et al. 1999). The responsiveness of the NSPCs to the growth factors depends on the expression of the corresponding EGF receptor (EGFR) and FGF receptor (FGFR), which are regulated in the respective manner (Burrows et al. 1997; Zhu et al. 1999). These receptor tyrosine kinases activate intracellular signaling cascades, including the mitogen-activated protein kinase (MAPK) pathway, which influences the proliferation and differentiation of neural progenitors (Bonni et al. 1997; Campos et al. 2004; Marshall 1995; Rajan and McKay 1998). The acquisition of the EGFR depends on the activation of the FGFR and therefore succeeds the latter (Ciccolini and Svendsen 1998; Lillien and Raphael 2000; Tropepe et al. 1999). The maturation from the FGFR-expressing immature towards the more mature FGFR- and EGFR-expressing state is considerably delayed in E12.5 telencephalic and E15 spinal cord-derived NSPCs obtained from tenascin-C (Tnc) knockout tissues (Garcion et al. 2004; Karus et al. 2011). The maturation deficit could be rescued by adding purified Tnc from postnatal CNS tissue to the Tnc−/−-deficient NSPCs in culture (Faissner et al. 2017; Kazanis and ffrench-Constant 2011; May et al. 2018). These observations clearly suggest that Tnc as a constituent of the niche intervenes in the maturation of NSPCs as an important extrinsic factor (Faissner et al. 2017; Kazanis and ffrench-Constant 2011; May et al. 2018).
Tenascin-C (Tnc) is a multimodular glycoprotein of the extracellular matrix that is expressed during embryonic and postnatal development in different neural and non-neural tissues (Joester and Faissner 2001). During brain development, Tnc can be found in the ventricular and subventricular zones of the lateral ventricles, where it is secreted by radial glia cells (Faissner et al. 2017; Garcion et al. 2001; Gates et al. 1995; Gotz et al. 1997; Temple 2001). During human development, it shows a prominent appearance in the outer SVZ, where basal radial glia serve as neurogenic stem cells (Pollen et al. 2015). In the proliferative zone of the lateral ventricle, the number of actively cycling cells is reduced when Tnc is missing in the homozygous knockout mutant (Garcion et al. 2001). This deficit coincides with the delayed acquisition of the EGFR expression of NSPCs and the correct differentiation of neurons, astrocytes, and oligodendrocytes (Garcion et al. 2001; Garcion et al. 2004; Karus et al. 2011). During later development and in adult mice, Tnc expression can be found in zones of active neurogenesis, whereas it is downregulated in other areas (Faissner et al. 2017; Gates et al. 1995; Miragall et al. 1990). New neurons are generated in the subventricular zone of the lateral ventricle and in the dentate gyrus of the hippocampus (Bond et al. 2015; Doetsch 2003; Ihrie and Alvarez-Buylla 2011; Kempermann et al. 2004). Tnc is localized in these niches and likely influences the proliferation and fate of the stem cells (Garcion et al. 2001; Garwood et al. 2012; Gates et al. 1995; Nakic et al. 1996).
The expression of Tnc is regulated by different extrinsic and intrinsic factors, including different cytokines and growth factors (Giblin and Midwood 2015). FGF-2 and EGF provoke an induction of Tnc expression in different cell culture systems like cortical or hippocampal astrocytes or different tumor cells (DiProspero et al. 1997; Mahler et al. 1997; Meiners et al. 1993; Rettig et al. 1989; Sakai et al. 1995; Smith and Hale 1997; Wirl et al. 1995). After injection of EGF into the adult lateral ventricle, the expression of Tnc by proliferative progenitor cells with glial character is strongly increased (Doetsch et al. 2002). Another factor that shows a strong inductive effect on Tnc expression in diverse cell culture systems is the transforming growth factor (TGF) β1 (Dobbertin et al. 2010; **nin et al. 2004; Mackie et al. 1998; Sakai et al. 1994; Smith and Hale 1997; Wirl et al. 1995). TGFβ1 is an important regulator of neural progenitor fate and survival (Falk et al. 2008; Wachs et al. 2006) and induces matrix molecule production in pathogenic situations, which leads to the rearrangement of tissue components in the brain (Dobbertin et al. 2003; Smith and Strunz 2005). Signaling by TGFβ1 involves the activation of the TGFβ receptors 1 and 2 and is conveyed to the nucleus via Smad proteins (Massague 1987; Wrana et al. 1994). Neural stem cells of the adult neural stem cell niche are arrested by TGFβ1 treatment, but their renewal capacity or differentiation potential is not affected (Kandasamy et al. 2014; Wachs et al. 2006).
These examples illustrate that it is not possible to predict the effect of distinct cytokines on the regulation of Tnc. Rather, the cell type and the specific context determine the response that eventually results from the interaction of different signal transduction pathways. In the present study, we therefore investigated the regulation of Tnc expression in NSPC cultures by the growth factors EGF, FGF-2, and TGFβ1. We used an in vitro model to determine the proliferative capacity of different NSPC populations of the mouse embryonic forebrain and analyzed the gene expression pattern of Tnc after long- and short-term stimulation.
Materials and methods
Animals and tissue preparation
Time-mated female NMRI mice were obtained from Charles River Laboratories (Sulzfeld, Germany) or from the in-house animal facility. The present study was carried out in accordance with the European Council Directive of September 22, 2010 (2010/63/EU), for care of laboratory animals and approved by the animal care committee of North Rhine-Westphalia, Germany, based at the LANUV (Landesamt für Natur, Umwelt und Verbraucherschutz Nordrhein-Westfalen, D-45659 Recklinghausen, Germany). The study was supervised by the animal welfare commissioner of the Ruhr University. Mice were kept according to the German animal protection law and FELASA (Federation for Laboratory Animals Science Association) standards in a 12-h light—12-h dark rhythm with water and food ad libitum. Pregnant females were detected by the appearance of a vaginal plug. They were sacrificed by cervical dislocation, and the embryos of the gestational day 13 (embryonic day (E)13, Theiler stage 21) were removed from the uterus and their brains dissected as described earlier (Sirko et al. 2007; von Holst et al. 2007, 2006). The cerebral cortex (Cor) and the ganglionic eminences (GE) were dissected, and the meninges were removed. The tissue was enzymatically treated with 0.05% trypsin–EDTA in HBSS (Invitrogen) for 10 min at 37 °C before the addition of ovomucoid: 1 mg/ml soybean trypsin inhibitor (Sigma-Aldrich), 50 µg/ml bovine serum albumin (BSA, Sigma-Aldrich), and 40 µg/ml DNaseI (Worthington) in L-15 medium (Sigma-Aldrich). Subsequently the tissue was mechanically triturated to obtain single cell suspensions. These were centrifuged, and the cell pellets were resuspended in neurosphere medium: DMEM/F-12 1:1 (both from Sigma-Aldrich) supplemented with 0.2 mg/ml L-glutamine (Sigma-Aldrich), 2% B27 (Invitrogen), 100 U/ml penicillin, and 100 U/ml streptomycin (Invitrogen).
Cell culture
Dissociated cells from E13 cortical or striatal (GE) embryonic brain tissue were cultured in neurosphere medium in a density of 100,000 cells per ml in the presence of the following growth factors: EGF 20 ng/ml (E; Peprotech #100–15), FGF-2 20 ng/ml (F; Peprotech #100-18B), EGF 20 ng/ml + FGF-2 20 ng/ml (E + F), TGFβ1 10 ng/ml (T; Peprotech #100–21), TGFβ1 10 ng/ml + EGF 20 ng/ml + FGF-2 20 ng/ml (T + E + F). A previous study involving dose–response analyses had revealed robust cellular responses when the cytokines were used in these concentration ranges (Dobbertin et al. 2003). In each FGF-2 containing condition, heparin (Sigma-Aldrich #H3149) was added as co-factor in a concentration of 0.5 U/ml. Control cells were cultured without any additional growth factor (Fig. 1).
The cells were allowed to grow for 3 days in the respective medium before they were used for RNA isolation. To follow the growth over a longer period, some cultures were kept up to 5 days in vitro (div). After that time, neurospheres in 20 randomly chosen visual fields that contained a minimum of 5 assembled cells were counted. The neurosphere index was then calculated by multiplying the mean number of neurospheres (n) with a specific size (larger than 5 cells, larger than 10 (20, 50, or 100) cells) with the respective size (n1 × 5 + n2 × 10 + n3 × 20 + n4 × 50 + n5 × 100). Because under some culture conditions the cells died after the third day (visible as cell debris under the microscope), we used neurospheres grown under optimal conditions with EGF and FGF-2 for further analysis after 1 week. These cultures were transferred to growth factor-free medium for 6 h to remove the bound factors before the different growth factor combinations were added over a period of 24 h, as described above.
To assess secondary neurospheres, EGF- and FGF-2-treated primary neurospheres were collected and dissociated to single cells after 1 week using trypsin–EDTA and re-plated for second passage in the presence of EGF and FGF-2. At the end of the second week, these cells were treated with the different growth factor combinations for 24 h. The different culture and treatment routines are depicted in the schematic representation in Fig. 1.
RNA isolation and RT-PCR
Neurosphere cells treated with different growth factors were harvested after a continuous treatment for 3 div or, alternatively, after a 24-h stimulus. The medium was removed from the cells by centrifugation, and their total RNA was isolated using the RNeasy Mini Kit (QIAGEN) following manufacturer’s instructions as described before (von Holst et al. 2007). To remove potentially contaminating genomic DNA we treated the RNA with DNase for 15 min (QIAGEN RNase free DNase Kit).
For cDNA synthesis, 1 µg of RNA was reverse transcribed using the First Strand cDNA Synthesis Kit (Fermentas/Thermo Scientific) with random hexamer primers in a total volume of 40 µl. In general, 1 µl of cDNA was used for a PCR reaction in a total volume of 25 µl using 1.5 mM MgCl2, 5 nmol of each dNTP, 1.25 U Taq polymerase, and 5 pmol of the appropriate forward (for) and reverse (rev) primers (Table 1). The reactions were incubated in a Mastercycler gradient (Eppendorf) with annealing temperatures as displayed in Table 1. The samples were analyzed on 1.5% agarose gels and digitally documented. Semi-quantitative endpoint analyses of the resulting band intensities were performed after background subtraction using ImageJ (NIH). Samples were first normalized to their respective GAPDH bands and then to the control conditions without growth factors. The statistical evaluation of three independent experiments (n = 3) was performed as one-way ANOVA with Bonferroni’s multiple comparison post hoc test using GraphPad Prism5 software.
Immunocytochemical staining
After a 24-h stimulus with the different growth factor combinations, some neurospheres were dissociated to single cells and plated onto poly-Ornithin (p-Orn, Sigma-Aldrich, 10 µg/ml)-coated cell culture dishes for 3 h. The cells were washed with Krebs–Ringer-HEPES (KRH: 125 mM NaCl, 4.8 mM KCl, 1.3 mM CaCl ⋅ 2H2O, 1.2 mM MgSO4 ⋅ 7H2O, 1.2 mM KH2PO4, 5.6 mM D-Glucose, 25 mM HEPES, pH 7.3) and incubated with a polyclonal anti-Tnc antibody (rabbit, batch KAF14 (Faissner and Kruse 1990), diluted 1:250 in KRH/A (KRH with 1% (w/v) BSA (Carl Roth)) for 25 min before fixation with 4% (w/v) paraformaldehyde (PFA). The cells were washed with PBS/A (phosphate-buffered saline (PBS, consisting of 137 mM NaCl, 3 mM KCl, 6.5 mM Na2HPO4 ⋅ 2H2O, 1.5 mM KH2PO4, pH 7.3) with 1% (w/v) BSA (Carl Roth)) and incubated with a Cy2-coupled anti-rabbit secondary antibody and Hoechst/bisbenzimide (1:105 in PBS/A) nuclear counterstain for 25 min. After washing with PBS/A and PBS, the dishes were mounted in PBS/glycerol (1:1) and documented using a fluorescence microscope (Axiophot 2, Zeiss).
Western blots
Neurosphere cells cultured with different growth factor combinations for 3 div were harvested by centrifugation and lysed in lysis buffer (50 mM Tris/Cl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 5 mM EGTA, 1% (v/v) Triton-X100, 0.1% (w/v) deoxycholate, 0.1% (w/v) sodium dodecyl sulfate (SDS), 40 mM sodium fluoride, 1 mM orthovanadate, pH 10) supplemented with the protease inhibitors PMSF (1 mM, MP Biomedicals), IAA (18.5 µg/ml, Sigma-Aldrich), SBTI (10 µg/ml, Sigma-Aldrich), Aprotinin (10 µg/ml, Sigma-Aldrich), Leupeptin (0.5 µg/ml, Sigma-Aldrich), and Pepstatin (0.1 µg/ml, Sigma-Aldrich) for 30 min on ice before the debris was removed by centrifugation. The conditioned medium was directly used for protein analysis. The lysates and supernatants were fractionated on a 4–10% gradient SDS polyacrylamide gel together with the Precision Plus Protein Dual Color Standard (Bio-Rad) and semi-dry blotted to methanol-activated polyvinylidene fluoride (PVDF) membranes. The membranes were blocked and incubated with antibodies for Tnc (polyclonal anti-Tnc, rabbit (batch KAF14), 1:3,000) and α-tubulin (DM1α, 1:10,000, Sigma-Aldrich), probed with appropriate HRP-coupled secondary antibodies (1:10,000, Dianova), and developed with the Clarity Western Blot ECL substrate (Bio-Rad).
Tissue preparation for cryosections
Embryonic whole mounts were fixed in 4% (w/v) PFA overnight and subsequently cryo-protected in 20% (w/v) sucrose in PBS treated with DEPC (diethyl pyrocarbonate, 1:1,000, autoclaving after overnight incubation). After settlement the tissue was frozen in tissue freezing medium (Leica) on dry ice before the sectioning of 14-µm slices in a Leica cryostat. Sections were immediately dry-mounted and stored at – 20 °C until use.
In situ hybridization
The protocol was adapted from Akita et al. (2008). Tissue sections were dried at room temperature and primed in 0.1 M TEA (triethanolamine hydrochloride, pH 8.0) before acetylation (0.25% (w/v) acetic anhydrate in TEA). After washing with 50 mM phosphate buffer (PB), slices were incubated for 2 h at 60 °C with hybridization buffer (50% (v/v) formamide, 10% (w/v) dextran sulfate, 1 × Denhardt’s reagent (Sigma-Aldrich), 100 µg/ml yeast RNA (Roche), 250 µg/ml salmon sperm DNA (Roche), 2 × SSC (standard saline citrate, prepared as 20 × SSC: 3 M NaCl, 0.3 M sodium citrate, pH 7.0), 50 mM sodium phosphate, pH 7.0, 0.2% (w/v) SDS). Subsequently, the sections were hybridized with a Tnc riboprobe (Czopka et al. 2009) 1:500 in hybridization buffer), which was denatured at 80 °C for 5 min before application. After overnight incubation at 60 °C, the sections were washed stringently at 60 °C in these buffers: 4 × SSC for 10 min, 2 × SSC containing 50% formamide for 20 min twice, 2 × SSC for 10 min, 0.2 × SSC for 20 min twice. The last two washing steps in Tris/NaCl buffer (0.15 M NaCl, 0.1 M Tris–HCl, pH 7.5) for 10 min were performed at room temperature, before the sections were blocked for 30 min with 1% (w/v) skimmed milk powder in Tris/NaCl buffer. Afterwards, the alkaline phosphatase-coupled anti-Dig Fab fragments (Roche) were applied (1:2,000 in blocking buffer) overnight at 4 °C. After washing with Tris/NaCl buffer thrice, the alkaline phosphatase substrates nitroblue tetrazolium (NBT, 0.34 mg/ml, Roche) and 5-bromo-4-chloro-3-indolyl phosphate (BCIP, 0.18 mg/ml, Roche) were applied in detection buffer containing 5% (w/v) polyvinyl alcohol, 0.1 M NaCl, 50 mM MgCl2, 0.1 M Tris–HCl, pH 9.5. The development of the color reaction was carried out at 37 °C and stopped with 1 mM EDTA, 10 mM Tris–HCl, pH 7.5 when clear signals were visible under microscopic control.
Immunohistochemistry
Cryosections were dried at room temperature and blocked with 5% (v/v) goat serum (Jackson Immuno Research) in PBS containing 1.7% (w/v) NaCl for 1 h, before the polyclonal anti-Tnc antibody (rabbit, batch KAF14) was applied 1:300 in PBT-1 (PBS with 1% (w/v) BSA (Carl Roth) and 0.1% (v/v) Triton X-100 (Sigma-Aldrich)). After overnight incubation and washing with PBS/A, the Cy3-coupled secondary antibody (anti-rabbit Cy3, 1:500, Dianova) was added in combination with Hoechst 33258 nuclear marker (1:105) in PBS/A for 2 h at room temperature. After washing with PBS, the sections were mounted with Immu-Mount (Shandon/Thermo Scientific) and documented with the Zeiss Axiophot 2.
Results
Proliferation of neural stem/progenitor cells of the forebrain is dependent on the presence of growth factors. Epidermal growth factor (EGF) and fibroblast growth factor (FGF-2) stimulate the proliferation of neural progenitors in vitro, which leads to the formation of freely floating cell aggregates, the so-called neurospheres (Ciccolini and Svendsen 1998; Reynolds et al. 1992). Neural stem/progenitor cells (NSPCs) isolated at embryonic day (E)13 from the dorsal (Cor) or ventral (GE) embryonic mouse forebrain generated neurospheres in culture (Fig. 2). The resulting spheres were counted and quantified using the neurosphere index, which combines the number of neurospheres and their respective size. Depending on the culture conditions, we observed considerable variability of sphere diameters. We decided not to exclude outliers in order to avoid introducing an observer’s bias. This resulted in large error bars in some cases (Fig. 2). Control cells without growth factor support yielded few and little spheres, but most of the cells died after about 3 days in the absence of trophic support, visible as cell debris. When EGF was added to the culture medium, viable neurospheres grew to a proper size, but their numbers remained low. More neurospheres arose when FGF-2 was supplied in the culture medium. However, when both growth factors were combined, the number and size of neurospheres were larger, resulting in higher indices. This observation strongly suggests that EGF and FGF-2 synergized to drive the expansion of neurospheres. This indicates that both cytokines acted independently, possibly stimulating different fractions of progenitor cells. This may explain why the combination of both factors led to the generation of more and larger neurospheres than either of the factors alone. As remarked previously, transforming growth factor (TGFβ1) had no stimulative effect on the proliferation of neural precursors (Falk et al. 2008; Siegenthaler and Miller 2005; Wachs et al. 2006). In contrast, TGFβ1 rather reduced the proliferation rate of the NSPCs when it was added to the promotive factors FGF-2 and EGF. This was visible for cortical cells and for cells from the GE (Fig. 2). Initially, TGFβ1-treated cells started proliferation during the first 3 days, but then suddenly stopped dividing and died between the 3rd and 5th day. In this they behaved like the control cultures in the absence of growth factors, indicative of missing trophic support (Fig. 2).
After the initial growth phase of 3 days in culture, we isolated the RNA of the precursor cells to determine the gene expression levels of genes of interest under the influence of the different growth factors. The cell cultures could be analyzed using this approach because they provided sufficient amounts of sample, as documented with the reference gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH), which was equally detectable in the different settings. NSPCs of the dorsal forebrain (Cor) did not express detectable amounts of EGF receptor (EGFR) yet (Fig. 3). In contrast, the FGF receptor (FGFR) was indeed present in each culture analyzed (Fig. 3) and presumably mediated the proliferative response. The neural development in the ventral forebrain appeared slightly faster than that of the dorsal forebrain, which was mirrored by the expression of the EGFR on the precursor cells (Ciccolini and Svendsen 1998; Martens et al. 2000). The receptor was already detectable in neurospheres from the GE. Therefore a stimulus with EGF could lead to a cellular response in this particular case. It has been demonstrated before that the presence of FGF-2 induces the gene expression of the EGFR (Lillien and Raphael 2000). This is in agreement with our results, because the EGFR was seen in all cultures where FGF-2 had been added (Fig. 3).
The expression of the TGFβR2 required the active signaling via EGF/EGFR, which had previously been documented in other studies (Yamane et al. 2007, 2003), e.g., for corneal epithelial cells (Shu et al. 2019). When EGFR activation was combined with the addition of FGF-2, the TGFβR2 expression was further enhanced, beyond a level obtained with FGF-2 treatment alone. This speaks in favor of a synergism of FGF-2 and EGF with regard to TGFβR2 expression that was maintained in the presence of TGFβ1, whereas TGFβ1 by itself completely repressed TGFβR2. The genes of the two other known TGFβ receptors TGFβR1 and TGFβR3 were detectable under all analyzed conditions and did not appear regulated by any of the growth factors used in this study (Fig. 3).
The strong regulation of the Tnc expression appeared most intriguing in our setting on mRNA level (Fig. 3) and on protein level (Fig. 4). Thus, the precursor cells from the cortex expressed only very weak levels of Tnc mRNA when no growth factor was present in the cultures (Fig. 3). This was expected because the expression of Tnc in situ was not yet prominent in this region at E13 (compare to Fig. 5). As soon as FGF-2 or EGF were added, the expression of the ECM molecule was strongly enhanced. FGF-2 stimulated the expression of Tnc in cortical cells, as well as in cultures from the GE (Fig. 3). This corresponds to the finding that Tnc expression in the ventral preceded upregulation in the dorsal forebrain and in Tnc expressing cells in the proliferative zone along the lateral ventricle in the GE (Fig. 5). In the cortex, the EGFR could not be found to be expressed at that early stage. Tnc expression in EGF-treated cortical NSPCs was negligible on mRNA level (Fig. 3). Contrarily, in ventrally derived cell cultures — where the EGFR could already be detected — the stimulation by EGF resulted in a strong increase of Tnc expression on mRNA level. Both growth factors combined resulted in a much stronger expression of Tnc in NSPCs that proved statistically significant. Also in this situation the addition of FGF-2 to EGF-responsive cells caused an augmented Tnc expression that exceeded notably what each factor could achieve by itself. The expression pattern of Tnc observed in vivo in E13 mouse embryos (Fig. 5) might be explained by the emergence of EGFR-positive neural progenitor cells and the subsequent activation of the intracellular signaling pathways leading to the increased transcription of the Tnc gene in neural progenitors of the glial lineage (Burrows et al. 1997; Temple 2001). Two days later, when gliogenesis begins at E15 and most of the progenitors in the lateral ventricular zones are responsive to EGF, the expression of Tnc expanded in the ventral as well as in the dorsal part along the whole ventricle (data not shown, and see Faissner et al. 2017).
TGFβ1 strongly promotes the expression of Tnc in numerous cell culture systems (Mackie et al. 1998; Sakai et al. 1994; Schnadelbach et al. 1998; Smith and Hale 1997; Wirl et al. 1995). As Tnc is released by NSPCs, we examined whether TGFβ1 also induces its upregulation in this context. In order to be activated by TGFβ1, the responsive cells need to express the type 2 receptor (Wrana et al. 1994). Cultures treated with a combination of EGF, FGF-2, and TGFβ1 expressed the TGFβR2, as detailed above. In the presence of TGFβ1, the neurosphere-forming capacity was clearly reduced. In contrast, the expression of Tnc was barely affected (Fig. 3). Message levels are not necessarily translated into different protein concentrations. In order to examine the consequences of factor exposure for downstream Tnc release, Western blots using the polyclonal Tnc antibody were performed (Fig. 4). The band intensities mirrored the outcome of the PCR analysis. The NSPCs secreted the ECM molecule into the medium, where it could weakly be detected in control and TGFβ1-treated cultures. EGF and FGF-2 strongly increased the amount of detectable Tnc, and the joint treatment with both growth factors exerted the most stimulatory effect on Tnc expression. The fact that EGF treatment had a slight, positive effect on neurosphere survival (Fig. 2) and on the Tnc expression, although the EGFR could not be detected by RT-PCR, leads to the question how EGF can exert these effects. Very low amounts of the EGFR, below the RT-PCR detection limit, might be expressed that mediate EGF signaling to a certain degree. As Tnc comprises several alternatively spliced domains (Joester and Faissner 1999; von Holst et al. 2007) and is highly glycosylated (Giblin and Midwood 2015), not one clearly circumscribed band was visible in the Western blot. Rather, Tnc glycoproteins distributed as rather diffuse bands covering a broad molecular weight range, in particular when the expression was substantial (Fig. 4).
The cell lysates (Fig. 4b, b’) also provided evidence for the regulation of Tnc protein by the growth factors, but the signals obtained were weaker. The protein fraction that was associated with the cell membranes or cell cytoplasm was less abundant than the secreted fraction. The cell lysates offered the opportunity to compare the protein amounts between the different culture conditions by comparison with the reference protein α-tubulin. The tubulin bands were similar for all cell cultures, confirming that comparable cell numbers were available in the samples. This underlined the regulatory impact of the growth factors with regard to Tnc in the samples under study (Fig. 4c, c’).
Because NSPC cultures in media devoid of growth factors or replenished solely with TGFβ1 displayed very limited growth after the third day in vitro and failed to express TGFβR2, an alternative approach was used to assess their responsiveness to a short-term exposure to different growth factors. In a first step, neurospheres were generated in the presence of EGF and FGF-2 and thereafter freed of potentially bound growth factors by incubation in growth factor-free medium for 6 h. Subsequently, NSPCs were treated with different cytokine combinations over a period of 24 h (see methods scheme in Fig. 1b). This procedure tempered any effect that could result from poor cell survival or proliferation and created equal starting conditions. This method also rendered possible the generation of secondary derived from primary neurospheres maintained in the presence of EGF and FGF-2 (Fig. 1c). The number of NSPCs in secondary was higher than in primary neurospheres, which could potentially lead to different expression patterns (Reynolds and Rietze 2005; Reynolds and Weiss 1996). Cells from the cortex and the GE treated with EGF and FGF-2 for 1 week expressed the TGFβ receptors TGFβR1, TGFβR2, and TGFβR3 (Fig. S1), which was not achieved after the shorter period of 3 days (Fig. 3). In this situation, therefore TGFβ1 could recruit TGFβR1 and TGFβR2. After 24 h we observed only faint expression of Tnc in control and TGFβ1-treated cultures, consistent with immunofluorescence analysis of dissociated cells and RT-PCR analysis performed with 1st and 2nd passage GE cultures (Fig. 6). Although the expression of the relevant receptors warranted the responsiveness of NSPCs, the exposure to TGFβ1 did not elevate Tnc expression in the first or the second passage. We conclude that TGFβ1 does not induce the expression of Tnc in neurosphere cells, different from what has been reported for diverse cell types of neural and non-neural origin (Mackie et al. 1998; Sakai et al. 1994; Smith and Hale 1997; Wirl et al. 1995).
In contrast, EGF or FGF-2, or both factors in combination strongly augmented Tnc expression in NSPCs. The protein was secreted by NSPCs that deposited a pericellular ECM in the respective environment around them, as visualized by immunostaining (Fig. 6a–f). Using RT-PCRs, we detected significantly stronger bands when the NSPCs were treated with EGF in cultures derived from the GE and also a similar tendency was seen in cells from the cortex (Fig. 6g, h–k). Because the EGF receptor was upregulated by FGF-2 in the antecedent culture condition, the difference between cortical and striatal cultures was waived. Consequently, EGF fostered a strong upregulation of the Tnc gene expression. FGF-2 also increased the transcription rate of Tnc, as expected for continuously treated cultures. Both factors led to a high expression level that reached saturation and could not be increased further, neither by the combination of both factors nor by the addition of TGFβ1 (Fig. 6). First and second passage NSPCs yielded similar results, which underlined that the stimulation of Tnc expression by EGF and FGF-2, but not by TGFβ1 proved a recurrent theme for these slightly different cultures. It is of interest to note that the stimulative effect by the classical growth factors of neurosphere cultures proved reversible, because cells initially treated with EGF and FGF-2 lost high Tnc expression when these factors were removed from the culture (Fig. 6).
Discussion
Stem cells of the develo** brain undergo symmetric and asymmetric divisions to enlarge the stem cell pool and generate differentiated cells of neural and glial lineages (Temple 2001). Along this pathway, NSPCs depend on the activity of growth factor signaling by EGF and FGF family members. When we analyzed the proliferation capacity of NSPCs in the presence of the growth factors EGF, FGF-2, and TGFβ1, we found that the progenitor cells divided frequently upon EGF and FGF-2 treatment, whereas TGFβ1 tempered their proliferation rate. The stimulation of NSPCs with EGF or FGF-2 resulted in the generation of neurospheres from embryonic forebrain tissues, in agreement with previous reports (Ciccolini and Svendsen 1998; Tropepe et al. 1999). As it had been reported for adult NSPCs, the addition of TGFβ1 led to a decreased proliferation rate of embryonic NSPCs, and the factor by itself was not able to prevent poor growth and regression of neurospheres. We assume that TGFβ1 rather arrested the stem cells in a non-proliferative, non-differentiating state, analogous to the adult neural stem cell response to TGFβ1 (Wachs et al. 2006).
Tnc is a constitutive compound of the stem cell niche in various organs (Chiquet-Ehrismann et al. 2014). Genetic transcriptome screens have revealed that Tnc is conspicuously enriched in neural stem cells in comparison with embryonic or hematopoietic stem cells (Ramalho-Santos et al. 2002). In vivo the localization of the ECM glycoprotein Tnc in the CNS coincides with the upregulation of the EGFR in the develo** forebrain, which suggests that Tnc is expressed by a resident subpopulation of progenitor cells. Indeed, cells with glial characteristics produce Tnc, which has especially been shown for radial glia cells serving as glial progenitors in this case (Faissner et al. 2017). Independently of EGF, also the cultivation of NSPCs in the presence of FGF-2 led to an upregulation of Tnc expression, but the EGF-dependent regulation resulted in a much more prominent increase. The neurosphere cultures reproduced the correct timing of forebrain development, shown by the EGFR and FGFR expression that could be detected in a developmental stage and region-dependent manner. The pattern of expression underpinned the basis for the stimulation of Tnc expression by cytokines. Both receptor systems involve the MAPK pathway that fosters an increase of proliferation (Campos et al. 2004). The MAPK signaling eventually impacts gene regulation in the nucleus, where it might induce an increase of Tnc expression. The maturation of the stem cells reflected by the acquisition of the EGFR is promoted by Tnc in the ECM environment, as evidenced by the observation that in Tnc-deficient mice the upregulation of the EGFR is delayed (Garcion et al. 2004; Karus et al. 2011).
In the adult mouse subventricular zone, slowly dividing stem cells generate transient amplifying type C cells that are EGF-responsive (Doetsch et al. 2002). Upon exposure to EGF, the type C cells downregulate Dlx2 and start to proliferate. The cells obtained from mature mouse brain displayed pronounced Tnc expression when cultured with EGF, which suggests stimulation of Tnc expression by this growth factor. Cells from this postnatal stage do express the EGFR, which renders them independent of FGF-2 dependent growth. Consequently, the injection of EGF into the lateral ventricle of adult mice leads to the upregulation of Tnc expression by the NSPC pool, which is localized there (Doetsch et al. 2002). In our present study, we provide further evidence that the response to EGF is not confined to adult, but can also be seen in embryonic NSPCs as soon as these have acquired EGFR expression.
TGFβ1 reduced the proliferation capacity of NSPCs from the embryonic forebrain, similar to what has been reported for cultures of adult neural stem cells and astrocytes (Vergeli et al. 1995; Wachs et al. 2006). In this respect the response to this external stimulus seems comparable between the different cell culture systems. Remarkably, we observed opposing effects regarding the stimulation of Tnc gene expression by TGFβ1. The cytokine strongly upregulates Tnc in cultures of primary astrocytes (Dobbertin et al. 2010), which did not occur in our NSPC cultures. Reactive astrocytes that produce ECM components contribute a pivotal cellular component of glial scars involved in the inhibition of axonal regeneration (Fitch and Silver 2008; Vogelaar et al. 2015). TGFβ1 is an inducer of glial scar formation both in vivo and in vitro (Howe et al. 2019; Song et al. 2019). Thus, reactive glia in lesion situations reacts differently to the TGFβ1 stimulus compared to NSPCs that represent actively cycling cells involved in tissue development and remodeling. Interestingly, also the response to EGF and FGF-2 differed between NSPCs and reactive astrocytes, because the latter do not increase Tnc production upon stimulation with either growth factor (Dobbertin et al. 2010). By comparison, EGF and FGF-2 promoted a strong upregulation of Tnc in NSPCs. This might indicate that the release of Tnc into the micromilieu of the neural NSPC niche is required to maintain the stemness and proliferative capacity of this cell population. The enrichment of Tnc in stem cell niches of the CNS and other organs supports this interpretation (Chiquet-Ehrismann et al. 2014; Faissner et al. 2017). It would be interesting to examine in which way adult neural stem cells respond to TGFβ1, because they share characteristics both with embryonic NSPC as well as with astrocytes. Considering regional differences, it is conceivable that TGFβ1 leads to distinct effects in cells from the midbrain, which showed stronger responsiveness to the factor than forebrain cells, in agreement with the report that these regions also display differential responses to the factor in vivo (Falk et al. 2008).
In conclusion, Tnc is regulated by growth factors in different and occasionally even opposed ways in selected tissues, depending on the cell type and the mode of presentation. Several studies reported an increased Tnc expression when cells are treated with TGFβ1, some of them distinguishing between the distinct splice variants of the molecule (Dobbertin et al. 2010). This is clearly not the case for NSPCs. FGF-2 stimulates Tnc expression both in neural and non-neural cell cultures (Chen et al. 2009; Meiners et al. 1993). Our findings clearly demonstrate an increased expression in FGF-2-treated NSPCs. This might generate a conducive microenvironment for proliferation and differentiation of the neural stem cell pool (Faissner et al. 2017).
References
Akita K, von Holst A, Furukawa Y, Mikami T, Sugahara K, Faissner A (2008) Expression of multiple chondroitin/dermatan sulfotransferases in the neurogenic regions of the embryonic and adult central nervous system implies that complex chondroitin sulfates have a role in neural stem cell maintenance. Stem Cells 26:798–809
Bond AM, Ming GL, Song H (2015) Adult mammalian neural stem cells and neurogenesis: five decades later. Cell Stem Cell 17:385–395
Bonni A, Sun Y, Nadal-Vicens M, Bhatt A, Frank DA, Rozovsky I, Stahl N, Yancopoulos GD, Greenberg ME (1997) Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science 278:477–483
Burrows RC, Wancio D, Levitt P, Lillien L (1997) Response diversity and the timing of progenitor cell maturation are regulated by developmental changes in EGFR expression in the cortex. Neuron 19:251–267
Campos LS, Leone DP, Relvas JB, Brakebusch C, Fässler R, Suter U, Ffrench-Constant C, (2004) Beta1 integrins activate a MAPK signalling pathway in neural stem cells that contributes to their maintenance. Development 131:3433–3444
Chen J, Guerriero E, Sado Y, SundarRaj N (2009) Rho-mediated regulation of TGF-beta1- and FGF-2-induced activation of corneal stromal keratocytes. Invest Ophthalmol vis Sci 50:3662–3670
Chiquet-Ehrismann R, Orend G, Chiquet M, Tucker RP, Midwood KS (2014) Tenascins in stem cell niches. Matrix Biology : Journal of the International Society for Matrix Biology 37:112–123
Ciccolini F, Svendsen CN (1998) Fibroblast growth factor 2 (FGF-2) promotes acquisition of epidermal growth factor (EGF) responsiveness in mouse striatal precursor cells: identification of neural precursors responding to both EGF and FGF-2. J Neurosci 18:7869–7880
Czopka T, Von Holst A, Schmidt G, ffrench-Constant C, Faissner A (2009) Tenascin C and tenascin R similarly prevent the formation of myelin membranes in a RhoA-dependent manner, but antagonistically regulate the expression of myelin basic protein via a separate pathway. Glia 57:1790–1801
Dimou L, Götz M (2014) Glial cells as progenitors and stem cells: new roles in the healthy and diseased brain. Physiol Rev 94:709–737
DiProspero NA, Meiners S, Geller HM (1997) Inflammatory cytokines interact to modulate extracellular matrix and astrocytic support of neurite outgrowth. Exp Neurol 148:628–639
Dobbertin A, Czvitkovich S, Theocharidis U, Garwood J, Andrews MR, Properzi F, Lin R, Fawcett JW, Faissner A (2010) Analysis of combinatorial variability reveals selective accumulation of the fibronectin type III domains B and D of tenascin-C in injured brain. Exp Neurol 225:60–73
Dobbertin A, Rhodes KE, Garwood J, Properzi F, Heck N, Rogers JH, Fawcett JW, Faissner A (2003) Regulation of RPTPbeta/phosphacan expression and glycosaminoglycan epitopes in injured brain and cytokine-treated glia. Mol Cell Neurosci 24:951–971
Doetsch F (2003) A niche for adult neural stem cells. Curr Opin Genet Dev 13:543–550
Doetsch F, Petreanu L, Caille I, Garcia-Verdugo JM, Alvarez-Buylla A (2002) EGF converts transit-amplifying neurogenic precursors in the adult brain into multipotent stem cells. Neuron 36:1021–1034
Faissner A, Kruse J (1990) J1/tenascin is a repulsive substrate for central nervous system neurons. Neuron 5:627–637
Faissner A, Roll L, Theocharidis U (2017) Tenascin-C in the matrisome of neural stem and progenitor cells. Mol Cell Neurosci 81:22–31
Falk S, Wurdak H, Ittner LM, Ille F, Sumara G, Schmid MT, Draganova K, Lang KS, Paratore C, Leveen P, Suter U, Karlsson S, Born W, Ricci R, Götz M, Sommer L (2008) Brain area-specific effect of TGF-beta signaling on Wnt-dependent neural stem cell expansion. Cell Stem Cell 2:472–483
Fitch MT, Silver J (2008) CNS injury, glial scars, and inflammation: inhibitory extracellular matrices and regeneration failure. Exp Neurol 209:294–301
Garcion E, Faissner A, ffrench-Constant C (2001) Knockout mice reveal a contribution of the extracellular matrix molecule tenascin-C to neural precursor proliferation and migration. Development 128:2485–2496
Garcion E, Halilagic A, Faissner A, ffrench-Constant C (2004) Generation of an environmental niche for neural stem cell development by the extracellular matrix molecule tenascin C. Development 131:3423–3432
Garwood J, Theocharidis U, Calco V, Dobbertin A, Faissner A (2012) Existence of tenascin-C isoforms in rat that contain the alternatively spliced AD1 domain are developmentally regulated during hippocampal development. Cell Mol Neurobiol 32:279–287
Gates MA, Thomas LB, Howard EM, Laywell ED, Sa** B, Faissner A, Götz B, Silver J, Steindler DA (1995) Cell and molecular analysis of the develo** and adult mouse subventricular zone of the cerebral hemispheres. J Comp Neurol 361:249–266
Giblin SP, Midwood KS (2015) Tenascin-C: form versus function. Cell Adh Migr 9:48–82
Götz M, Bolz J, Joester A, Faissner A (1997) Tenascin-C synthesis and influence on axonal growth during rat cortical development. Eur J Neurosci 9:496–506
Heide M, Long KR, Huttner WB (2017) Novel gene function and regulation in neocortex expansion. Curr Opin Cell Biol 49:22–30
Howe MD, Furr JW, Munshi Y, Roy-O’Reilly MA, Maniskas ME, Koellhoffer EC, d’Aigle J, Sansing LH, McCullough LD, Urayama A (2019) Transforming growth factor-beta promotes basement membrane fibrosis, alters perivascular cerebrospinal fluid distribution, and worsens neurological recovery in the aged brain after stroke. Geroscience 41:543–559
Ihrie RA, Alvarez-Buylla A (2011) Lake-front property: a unique germinal niche by the lateral ventricles of the adult brain. Neuron 70:674–686
**nin M, Ihn H, Asano Y, Yamane K, Trojanowska M, Tamaki K (2004) Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1. Oncogene 23:1656–1667
Joester A, Faissner A (1999) Evidence for combinatorial variability of tenascin-C isoforms and developmental regulation in the mouse central nervous system. J Biol Chem 274:17144–17151
Joester A, Faissner A (2001) The structure and function of tenascins in the nervous system. Matrix Biology : Journal of the International Society for Matrix Biology 20:13–22
Kandasamy M, Lehner B, Kraus S, Sander PR, Marschallinger J, Rivera FJ, Trümbach D, Ueberham U, Reitsamer HA, Strauss O, Bogdahn U, Couillard-Despres S, Aigner L (2014) TGF-beta signalling in the adult neurogenic niche promotes stem cell quiescence as well as generation of new neurons. J Cell Mol Med 18:1444–1459
Karus M, Denecke B, ffrench-Constant C, Wiese S, Faissner A (2011) The extracellular matrix molecule tenascin C modulates expression levels and territories of key patterning genes during spinal cord astrocyte specification. Development 138:5321–5331
Kazanis I, ffrench-Constant C (2011) Extracellular matrix and the neural stem cell niche. Dev Neurobiol 71:1006–1017
Kempermann G, Wiskott L, Gage FH (2004) Functional significance of adult neurogenesis. Curr Opin Neurobiol 14:186–191
Lillien L, Raphael H (2000) BMP and FGF regulate the development of EGF-responsive neural progenitor cells. Development 127:4993–5005
Mackie EJ, Abraham LA, Taylor SL, Tucker RP, Murphy LI (1998) Regulation of tenascin-C expression in bone cells by transforming growth factor-beta. Bone 22:301–307
Mahler M, Ben-Ari Y, Represa A (1997) Differential expression of fibronectin, tenascin-C and NCAMs in cultured hippocampal astrocytes activated by kainate, bacterial lipopolysaccharide or basic fibroblast growth factor. Brain Res 775:63–73
Marshall CJ (1995) Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179–185
Martens DJ, Tropepe V, van Der Kooy D (2000) Separate proliferation kinetics of fibroblast growth factor-responsive and epidermal growth factor-responsive neural stem cells within the embryonic forebrain germinal zone. J Neurosci 20:1085–1095
Martynoga B, Drechsel D, Guillemot F (2012) Molecular control of neurogenesis: a view from the mammalian cerebral cortex. Cold Spring Harb Perspect Biol 4
Massagué J (1987) The TGF-beta family of growth and differentiation factors. Cell 49:437–438
May M, Denecke B, Schroeder T, Götz M, Faissner A (2018) Cell tracking in vitro reveals that the extracellular matrix glycoprotein Tenascin-C modulates cell cycle length and differentiation in neural stem/progenitor cells of the develo** mouse spinal cord. Biol Open 7
Meiners S, Marone M, Rittenhouse JL, Geller HM (1993) Regulation of astrocytic tenascin by basic fibroblast growth factor. Dev Biol 160:480–493
Miragall F, Kadmon G, Faissner A, Antonicek H, Schachner M (1990) Retention of J1/tenascin and the polysialylated form of the neural cell adhesion molecule (N-CAM) in the adult olfactory bulb. J Neurocytol 19:899–914
Nakic M, Mitrovic N, Sperk G, Schachner M (1996) Kainic acid activates transient expression of tenascin-C in the adult rat hippocampus. J Neurosci Res 44:355–362
Pacary E, Martynoga B, Guillemot F (2012) Crucial first steps: the transcriptional control of neuron delamination. Neuron 74:209–211
Pollen AA, Nowakowski TJ, Chen J, Retallack H, Sandoval-Espinosa C, Nicholas CR, Shuga J, Liu SJ, Oldham MC, Diaz A, Lim DA, Leyrat AA, West JA, Kriegstein AR (2015) Molecular identity of human outer radial glia during cortical development. Cell 163:55–67
Rajan P, McKay RD (1998) Multiple routes to astrocytic differentiation in the CNS. J Neurosci 18:3620–3629
Ramalho-Santos M, Yoon S, Matsuzaki Y, Mulligan RC, Melton DA (2002) “Stemness”: transcriptional profiling of embryonic and adult stem cells. Science 298:597–600
Reinhard J, Brösicke N, Theocharidis U, Faissner A (2016) The extracellular matrix niche microenvironment of neural and cancer stem cells in the brain. Int J Biochem Cell Biol 81:174–183
Rettig WJ, Triche TJ, Garin-Chesa P (1989) Stimulation of human neuronectin secretion by brain-derived growth factors. Brain Res 487:171–177
Reynolds BA, Rietze RL (2005) Neural stem cells and neurospheres–re-evaluating the relationship. Nat Methods 2:333–336
Reynolds BA, Tetzlaff W, Weiss S (1992) A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes. J Neurosci 12:4565–4574
Reynolds BA, Weiss S (1992) Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255:1707–1710
Reynolds BA, Weiss S (1996) Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Dev Biol 175:1–13
Sakai T, Kawakatsu H, Ohta M, Saito M (1994) Tenascin induction in tenascin nonproducing carcinoma cell lines in vivo and by TGF-beta 1 in vitro. J Cell Physiol 159:561–572
Sakai T, Ohta M, Furukawa Y, Saga Y, Aizawa S, Kawakatsu H, Saito M (1995) Tenascin-C induction by the diffusible factor epidermal growth factor in stromal-epithelial interactions. J Cell Physiol 165:18–29
Schnädelbach O, Mandl C, Faissner A (1998) Expression of DSD-1-PG in primary neural and glial-derived cell line cultures, upregulation by TGF-beta, and implications for cell-substrate interactions of the glial cell line Oli-neu. Glia 23:99–119
Shu DY, Hutcheon AEK, Zieske JD, Guo X (2019) Epidermal growth factor stimulates transforming growth factor-beta receptor type II expression in corneal epithelial cells. Sci Rep 9:8079
Siegenthaler JA, Miller MW (2005) Transforming growth factor beta 1 promotes cell cycle exit through the cyclin-dependent kinase inhibitor p21 in the develo** cerebral cortex. J Neurosci 25:8627–8636
Sirko S, von Holst A, Wizenmann A, Götz M, Faissner A (2007) Chondroitin sulfate glycosaminoglycans control proliferation, radial glia cell differentiation and neurogenesis in neural stem/progenitor cells. Development 134:2727–2738
Smith GM, Hale JH (1997) Macrophage/Microglia regulation of astrocytic tenascin: synergistic action of transforming growth factor-beta and basic fibroblast growth factor. J Neurosci 17:9624–9633
Smith GM, Strunz C (2005) Growth factor and cytokine regulation of chondroitin sulfate proteoglycans by astrocytes. Glia 52:209–218
Song G, Yang R, Zhang Q, Chen L, Huang D, Zeng J, Yang C, Zhang T (2019) TGF-beta secretion by M2 macrophages induces glial scar formation by activating astrocytes in vitro. Journal of Molecular Neuroscience : MN 69:324–332
Taverna E, Götz M, Huttner WB (2014) The cell biology of neurogenesis: toward an understanding of the development and evolution of the neocortex. Annu Rev Cell Dev Biol 30:465–502
Temple S (2001) The development of neural stem cells. Nature 414:112–117
Theocharidis U, Long K, Ffrench-Constant C, Faissner A (2014) Regulation of the neural stem cell compartment by extracellular matrix constituents. Prog Brain Res 214:3–28
Tropepe V, Sibilia M, Ciruna BG, Rossant J, Wagner EF, van der Kooy D (1999) Distinct neural stem cells proliferate in response to EGF and FGF in the develo** mouse telencephalon. Dev Biol 208:166–188
Vergeli M, mazzanti B, Ballerini C, Gran B, Amaducci L, Massacesi L (1995) Transforming growth factor-beta 1 inhibits the proliferation of rat astrocytes induced by serum and growth factors. J Neurosci Res 40:127–133
Vogelaar CF, König B, Krafft S, Estrada V, Brazda N, Ziegler B, Faissner A, Müller HW (2015) Pharmacological suppression of CNS scarring by deferoxamine reduces lesion volume and increases regeneration in an in vitro model for astroglial-fibrotic scarring and in rat spinal cord injury in vivo. PLoS One 10:e0134371
von Holst A, Egbers U, Prochiantz A, Faissner A (2007) Neural stem/progenitor cells express 20 tenascin C isoforms that are differentially regulated by Pax6. J Biol Chem 282:9172–9181
von Holst A, Sirko S, Faissner A (2006) The unique 473HD-chondroitinsulfate epitope is expressed by radial glia and involved in neural precursor cell proliferation. J Neurosci 26:4082–4094
Wachs FP, Winner B, Couillard-Despres S, Schiller T, Aigner R, Winkler J, Bogdahn U, Aigner L (2006) Transforming growth factor-beta1 is a negative modulator of adult neurogenesis. J Neuropathol Exp Neurol 65:358–370
Wirl G, Hermann M, Ekblom P, Fässler R (1995) Mammary epithelial cell differentiation in vitro is regulated by an interplay of EGF action and tenascin-C downregulation. J Cell Sci 108(Pt 6):2445–2456
Wrana JL, Attisano L, Wieser R, Ventura F, Massagué J (1994) Mechanism of activation of the TGF-beta receptor. Nature 370:341–347
Yamane K, Asano Y, Tamaki K, Ihn H (2007) Epidermal growth factor up-regulates transforming growth factor-beta receptor type II in human dermal fibroblasts via p38 mitogen-activated protein kinase pathway. Biochem Biophys Res Commun 352:69–77
Yamane K, Ihn H, Tamaki K (2003) Epidermal growth factor up-regulates expression of transforming growth factor beta receptor type II in human dermal fibroblasts by phosphoinositide 3-kinase/Akt signaling pathway: resistance to epidermal growth factor stimulation in scleroderma fibroblasts. Arthritis Rheum 48:1652–1666
Zhu G, Mehler MF, Mabie PC, Kessler JA (1999) Developmental changes in progenitor cell responsiveness to cytokines. J Neurosci Res 56:131–145
Acknowledgements
The authors thank Anke Mommsen for excellent technical assistance and the counting of neurospheres, Alexander von Holst for helpful discussions, and Sandra Simonis for her help.
Funding
Open Access funding enabled and organized by Projekt DEAL. We acknowledge grant support from the German Research Foundation (DFG, FA 159/23–1 to AF, and a stipend from the graduate training school GRK 736 "Development and Plasticity of the Nervous System" to UT).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval
The present study was carried out in accordance with the European Council Directive of September 22, 2010 (2010/63/EU) for care of laboratory animals and approved by the animal care committee of North Rhine-Westphalia, Germany, based at the LANUV (Landesamt für Natur, Umwelt und Verbraucherschutz Nordrhein-Westfalen, D-45659 Recklinghausen, Germany). The study was supervised by the animal welfare commissioner of Ruhr University. Male and female mice were housed individually with a constant 12-h light–dark cycle and access to food and water ad libitum. All efforts were made to reduce the number of animals in the experiments. Embryos of both sexes were used.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Theocharidis, U., Roll, L. & Faissner, A. The expression of tenascin-C in neural stem/progenitor cells is stimulated by the growth factors EGF and FGF-2, but not by TGFβ1. Cell Tissue Res 385, 659–674 (2021). https://doi.org/10.1007/s00441-021-03508-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00441-021-03508-6